Intuitive Surgical Q3 revenue rises 22% to $3.05B as net income declines
Intuitive Surgical Q3 2026: revenue up 22% to $3.05B, while net income fell 25.8% to $522.8M and diluted EPS dropped to $1.49, per TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Intuitive Surgical reported third-quarter 2026 revenue of $3.05B, up 22% from a year earlier, according to a TradingView summary of the company's 10-Q filing. Net income attributable to the company fell to $522.8M from $704.4M, and diluted EPS came in at $1.49 versus $1.95 a year earlier.
Revenue growth was driven by an 18% rise in instruments and accessories and a 30% increase in system sales. The da Vinci installed base reached 12,094 systems (up 12%), including 2,023 da Vinci 5 systems, and about 906K procedures were performed in the quarter (up 14%). The Ion platform installed base grew to 1,152 systems (up 21%), with procedures up 31%. The company also recognized IEEPA tariff refunds that supported its gross margin.
why it matters
Revenue growing faster than profit points to pressure on profitability, although tariff refunds helped margins. Investors in the medtech sector will focus on growth in the installed base and procedures, as well as the leasing share: 53% of Q3 system placements were leases with usage-based revenue.
market impact
Medtech and ISRG: revenue outpaces profit growth, shifting attention to margins and tariff effects
tags
instruments
sources
- Intuitive Surgical 3Q 2026: Revenue $3.05B, EPS $1.49— 10-Q Summary — TradingView, 21 October 2026 at 21:21 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗